Results 51 to 60 of about 77,233 (255)
Real‐World Safety of Concomitant Colchicine and Statin Therapy
Arthritis Care &Research, EarlyView.Objective This study aimed to evaluate the risk of clinically meaningful muscle‐ and liver‐related outcomes associated with concomitant colchicine–statin therapy in a real‐world setting, and to determine whether concomitant therapy increases the incidence of toxicity compared with either agent alone.
Roni Meidan +5 more
wiley +1 more source
Polypharmacy in Elderly: Overview, Prevalence and Psychiatric Perspectives
Journal of the Indian Academy of Geriatrics, 2019 Introduction: Ageing is a natural phenomenon that is accompanied by a cascade of unwanted and unintended circumstances or problems that are always undesirable but not still avoidable.
Priya Sharma, P Khuda, N L Gupta
doaj +1 more source
Journal of Primary Care & Community Health, 2023 Objectives: To investigate the prevalence and predictors of excessive polypharmacy in geriatric inpatients in Indonesia. Methods: This retrospective cross-sectional study included 1533 inpatients over the age of 60 years at Universitas Airlangga Hospital,
Shah Faisal +5 more
doaj +1 more source
Advanced Science, EarlyView.This berberine‐loaded dual‐dynamically crosslinked nanogel integrates tannic acid‐zinc metal‐phenolic networks and carboxymethyl chitosan/aldehyde‐functionalized poly(ethylene glycol) dynamic Schiff base networks, achieving 1‐year colloidal and antioxidant stability, sustained corneal berberine exposure for 24 h to support convenient once‐daily dosing,
Yanru Xin +7 more
wiley +1 more source
Survey of polypharmacy prescription in a tertiary care Hospital, Belagavi
Kanem Journal of Medical Sciences, 2021 Background: Polypharmacy is the use of four or more medications in one prescription or implies the prescription of too many medications for an individual. Concerns about polypharmacy include increase adverse drug reactions, drug interactions, prescribing
Suma Sukumaran +6 more
doaj +1 more source
Advanced Science, EarlyView.Clinical symptoms offer a window into multimorbidity. A macro‐micro heterogeneous graph neural network integrates clinical records with biomedical knowledge to improve patient‐level symptom‐disease association learning and visit‐level multimorbidity completion.
Yiheng Ye +15 more
wiley +1 more source
Polypharmacy management by 2030: a patient safety challenge. [PDF]
, 2017 The SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) consortium have explored how healthcare management programmes can be implemented to improve medication safety and prevent patient harm by addressing the ...
Kempen, Thomas +11 more
core
Chinese Expert Consensus on the Clinical Application of Finerenone in Geriatric Comorbidities
AGING MEDICINE, EarlyView.Mineralocorticoid receptor (MR) overactivation drives inflammation, oxidative stress, and fibrosis in the heart, kidneys, and vasculature, leading to cardiorenal dysfunction. MR signaling promotes hypertrophy, remodeling, and injury through pathways like oxidative stress and inflammation, resulting in vascular stiffness and progressive organ damage ...
Xiaoming Wang, Cuntai Zhang
wiley +1 more source
Is Excessive Polypharmacy a Transient or Persistent Phenomenon? A Nationwide Cohort Study in Taiwan
Frontiers in Pharmacology, 2018 Objectives: Target populations with persistent polypharmacy should be identified prior to implementing strategies against inappropriate medication use, yet limited information regarding such populations is available.
Yi-Jen Wang +12 more
doaj +1 more source
, 2022 Objective:Polypharmacy brings with it the risk of potential drug interaction. This study aimed to investigate polypharmacy, potential drug interactions, the drug interactions causing neurological symptoms in geriatric patients with epilepsy, and ...
Bahar Erbaş
core +1 more source